These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 34077532)

  • 1. Toxicity of pathogenic ataxin-2 in Drosophila shows dependence on a pure CAG repeat sequence.
    McGurk L; Rifai OM; Shcherbakova O; Perlegos AE; Byrns CN; Carranza FR; Zhou HW; Kim HJ; Zhu Y; Bonini NM
    Hum Mol Genet; 2021 Sep; 30(19):1797-1810. PubMed ID: 34077532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PolyQ repeat expansions in ATXN2 associated with ALS are CAA interrupted repeats.
    Yu Z; Zhu Y; Chen-Plotkin AS; Clay-Falcone D; McCluskey L; Elman L; Kalb RG; Trojanowski JQ; Lee VM; Van Deerlin VM; Gitler AD; Bonini NM
    PLoS One; 2011 Mar; 6(3):e17951. PubMed ID: 21479228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ATXN2-AS, a gene antisense to ATXN2, is associated with spinocerebellar ataxia type 2 and amyotrophic lateral sclerosis.
    Li PP; Sun X; Xia G; Arbez N; Paul S; Zhu S; Peng HB; Ross CA; Koeppen AH; Margolis RL; Pulst SM; Ashizawa T; Rudnicki DD
    Ann Neurol; 2016 Oct; 80(4):600-15. PubMed ID: 27531668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous ALS and SCA2 associated with an intermediate-length
    Ghahremani Nezhad H; Franklin JP; Alix JJP; Moll T; Pattrick M; Cooper-Knock J; Shanmugarajah P; Beauchamp NJ; Hadjivissiliou M; Paling D; Mcdermott C; Shaw PJ; Jenkins TM
    Amyotroph Lateral Scler Frontotemporal Degener; 2021 Nov; 22(7-8):579-582. PubMed ID: 33284045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA toxicity is a component of ataxin-3 degeneration in Drosophila.
    Li LB; Yu Z; Teng X; Bonini NM
    Nature; 2008 Jun; 453(7198):1107-11. PubMed ID: 18449188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genes and pathways affected by CAG-repeat RNA-based toxicity in Drosophila.
    Shieh SY; Bonini NM
    Hum Mol Genet; 2011 Dec; 20(24):4810-21. PubMed ID: 21933837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Model organisms reveal insight into human neurodegenerative disease: ataxin-2 intermediate-length polyglutamine expansions are a risk factor for ALS.
    Bonini NM; Gitler AD
    J Mol Neurosci; 2011 Nov; 45(3):676-83. PubMed ID: 21660502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Motor neurone disease/amyotrophic lateral sclerosis associated with intermediate-length CAG repeat expansions in Ataxin-2 does not have 1C2-positive polyglutamine inclusions.
    Highley JR; Lorente Pons A; Cooper-Knock J; Wharton SB; Ince PG; Shaw PJ; Wood J; Kirby J
    Neuropathol Appl Neurobiol; 2016 Jun; 42(4):377-89. PubMed ID: 26095883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spinocerebellar Ataxia Type 2.
    Scoles DR; Pulst SM
    Adv Exp Med Biol; 2018; 1049():175-195. PubMed ID: 29427103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FTLD-ALS of TDP-43 type and SCA2 in a family with a full ataxin-2 polyglutamine expansion.
    Bäumer D; East SZ; Tseu B; Zeman A; Hilton D; Talbot K; Ansorge O
    Acta Neuropathol; 2014 Oct; 128(4):597-604. PubMed ID: 24718895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ATXN2 CAG repeat expansions increase the risk for Chinese patients with amyotrophic lateral sclerosis.
    Liu X; Lu M; Tang L; Zhang N; Chui D; Fan D
    Neurobiol Aging; 2013 Sep; 34(9):2236.e5-8. PubMed ID: 23635656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ATXN2 intermediate repeat expansions influence the clinical phenotype in frontotemporal dementia.
    Rubino E; Mancini C; Boschi S; Ferrero P; Ferrone M; Bianca S; Zucca M; Orsi L; Pinessi L; Govone F; Vacca A; Gai A; Giordana MT; Brusco A; Rainero I
    Neurobiol Aging; 2019 Jan; 73():231.e7-231.e9. PubMed ID: 30342763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetics DNA methylation in the core ataxin-2 gene promoter: novel physiological and pathological implications.
    Laffita-Mesa JM; Bauer PO; Kourí V; Peña Serrano L; Roskams J; Almaguer Gotay D; Montes Brown JC; Martínez Rodríguez PA; González-Zaldívar Y; Almaguer Mederos L; Cuello-Almarales D; Aguiar Santiago J
    Hum Genet; 2012 Apr; 131(4):625-38. PubMed ID: 22037902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ATXN2 is a modifier of phenotype in ALS patients of Sardinian ancestry.
    Borghero G; Pugliatti M; Marrosu F; Marrosu MG; Murru MR; Floris G; Cannas A; Parish LD; Cau TB; Loi D; Ticca A; Traccis S; Manera U; Canosa A; Moglia C; Calvo A; Barberis M; Brunetti M; Renton AE; Nalls MA; Traynor BJ; Restagno G; Chiò A;
    Neurobiol Aging; 2015 Oct; 36(10):2906.e1-5. PubMed ID: 26208502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of (CAG)
    Zhou X; Wang C; Ding D; Chen Z; Peng Y; Peng H; Hou X; Wang P; Hou X; Ye W; Li T; Yang H; Qiu R; Xia K; Sequeiros J; Tang B; Jiang H
    Sci Rep; 2018 Mar; 8(1):3889. PubMed ID: 29497168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyotrophic lateral sclerosis and spinocerebellar ataxia type 2 in a family with full CAG repeat expansions of ATXN2.
    Tazen S; Figueroa K; Kwan JY; Goldman J; Hunt A; Sampson J; Gutmann L; Pulst SM; Mitsumoto H; Kuo SH
    JAMA Neurol; 2013 Oct; 70(10):1302-4. PubMed ID: 23959108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency of SCA1, SCA2, SCA3/MJD, SCA6, SCA7, and DRPLA CAG trinucleotide repeat expansion in patients with hereditary spinocerebellar ataxia from Chinese kindreds.
    Tang B; Liu C; Shen L; Dai H; Pan Q; Jing L; Ouyang S; Xia J
    Arch Neurol; 2000 Apr; 57(4):540-4. PubMed ID: 10768629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeat Associated Non-AUG Translation (RAN Translation) Dependent on Sequence Downstream of the ATXN2 CAG Repeat.
    Scoles DR; Ho MH; Dansithong W; Pflieger LT; Petersen LW; Thai KK; Pulst SM
    PLoS One; 2015; 10(6):e0128769. PubMed ID: 26086378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TR-FRET-Based Immunoassay to Measure Ataxin-2 as a Target Engagement Marker in Spinocerebellar Ataxia Type 2.
    Bux J; Sen NE; Klink IM; Hauser S; Synofzik M; Schöls L; Auburger G; Riess O; Hübener-Schmid J
    Mol Neurobiol; 2023 Jun; 60(6):3553-3567. PubMed ID: 36894829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of ATXN2 trinucleotide repeats in Korean patients with amyotrophic lateral sclerosis.
    Kim YE; Oh KW; Noh MY; Park J; Kim HJ; Park JE; Ki CS; Kim SH
    Neurobiol Aging; 2018 Jul; 67():201.e5-201.e8. PubMed ID: 29665996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.